HepConnect supports programs and services designed to reach people in need.
In response to the intersecting opioid and hepatitis C virus (HCV) epidemics in the U.S., in 2019 we launched HepConnect, a five-year, multi-million-dollar initiative to help address the increase in HCV and support community partnerships in Indiana, Kentucky, North Carolina, Tennessee and West Virginia.
HepConnect has three areas of focus:
- Expand Screening and Linkage to Care
- Support Harm Reduction and Community Education
- Activate Healthcare Infrastructure
Expand Screening and Linkage to Care
HepConnect supports local community partnerships to expand testing for the virus and support access to healthcare.
- HCV does not always cause symptoms immediately. Testing is the first step to ensure people receive treatment.
- Access to healthcare can be difficult in rural areas, including much of greater Appalachia.
- Many residents of the region lack insurance coverage, limiting their ability to get the care they need.